Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filomena Emanuela Laddaga

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|September 13, 2025
Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical StrategiesFilomena Emanuela Laddaga, Mario Della Mura, Joana Sorino, et al.
Cancers|December 17, 2024
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced ToxicityFilomena Emanuela Laddaga, Michele Telegrafo, Carmela Garzillo, et al.
Annals of Hematology|April 19, 2019
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphomaFrancesco Gaudio, Claudia Nardelli, Paola Masciandaro, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2020
Long-term Hodgkin Lymphoma Survivors: A Glimpse of What Happens 10 Years After TreatmentFilomena Emanuela Laddaga, Marco Moschetta, Tommasina Perrone, et al.
Journal of Clinical Pathology|May 20, 2021
Correlation between circulating blood and microenvironment T lymphocytes in diffuse large B-cell lymphomasFilomena Emanuela Laddaga, Giuseppe Ingravallo, Anna Mestice, et al.
Annals of Hematology|January 25, 2018
Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomasFrancesco Gaudio, Roberto Tamma, Giuseppe Ingravallo, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2025
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive OverviewAmanda Caruso, Filomena Emanuela Laddaga, Alba Fiorentino, et al.
Annals of Hematology|November 25, 2024
Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomasFrancesco Gaudio, Anna Mele, Eleonora Prete, et al.
British Journal of Haematology|August 31, 2021
In male Hodgkin lymphoma patients, impaired fertility may be improved by non-gonadotoxic therapyFilomena Emanuela Laddaga, Pierluigi Masciopinto, Claudia Nardelli, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2018
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin LymphomaFrancesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|September 13, 2025
Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical StrategiesFilomena Emanuela Laddaga, Mario Della Mura, Joana Sorino, et al.
Cancers|December 17, 2024
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced ToxicityFilomena Emanuela Laddaga, Michele Telegrafo, Carmela Garzillo, et al.
Annals of Hematology|April 19, 2019
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin's lymphomaFrancesco Gaudio, Claudia Nardelli, Paola Masciandaro, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2020
Long-term Hodgkin Lymphoma Survivors: A Glimpse of What Happens 10 Years After TreatmentFilomena Emanuela Laddaga, Marco Moschetta, Tommasina Perrone, et al.
Journal of Clinical Pathology|May 20, 2021
Correlation between circulating blood and microenvironment T lymphocytes in diffuse large B-cell lymphomasFilomena Emanuela Laddaga, Giuseppe Ingravallo, Anna Mestice, et al.
Annals of Hematology|January 25, 2018
Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomasFrancesco Gaudio, Roberto Tamma, Giuseppe Ingravallo, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2025
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive OverviewAmanda Caruso, Filomena Emanuela Laddaga, Alba Fiorentino, et al.
Annals of Hematology|November 25, 2024
Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomasFrancesco Gaudio, Anna Mele, Eleonora Prete, et al.
British Journal of Haematology|August 31, 2021
In male Hodgkin lymphoma patients, impaired fertility may be improved by non-gonadotoxic therapyFilomena Emanuela Laddaga, Pierluigi Masciopinto, Claudia Nardelli, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2018
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin LymphomaFrancesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, et al.
Pageof 2